School of Medicine
Showing 1-4 of 4 Results
-
Kathryn (Katie) Kapp
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsI am interested in using mass spectrometry to study protein glycosylation, a complex post-translational modification that is known to be heavily altered in cancer. Protein glycosylation could improve early cancer detection. I am using mass spectrometry to study protein glycosylation in a variety of clinical samples and cancers, but I am particularly interested in proximal fluid samples to develop sources of less invasive biomarkers.
-
Donghoon Kim
Postdoctoral Scholar, Radiology
BioDr. Donghoon Kim is a postdoctoral scholar at Stanford's Center for Advanced Functional Neuroimaging. His research focuses on developing cutting-edge techniques for analyzing multimodal neuroimaging using deep learning-based methods.
Before joining Stanford, he earned his Ph.D. in Biomedical Engineering from University of California, Davis. His Ph.D. thesis was titled "Deep Learning-Driven Technical Developments and Clinical Applications of Arterial Spin Labeling MRI". During his Ph.D. studies, he focused on the development of advanced deep learning techniques for ASL MRI, and its clinical applications. During his master's degree in Biomedical Engineering at Virginia Tech-Wake Forest University, he studied the functional connectivity of the default mode network using resting state BOLD fMRI among youth football players. -
Manoj Kumar
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsI work on imaging-guided therapy using PET and MR imaging approaches. My academic training and background is in molecular imaging. During my doctoral training, I developed and validated a PET imaging approach for evaluating endocrine therapy responses in advanced breast cancer. My current research focuses on imaging tumor immune markers and responses to cancer immunotherapy. The goal is to develop new imaging toolboxes to monitor and guide treatment. Specifically, I employ antibodies, nanoparticles, and reporter genes for imaging and combinations of therapies to modulate and restore the body's suppressed immune functions against cancer cells. This is being done in collaboration with teams of researchers in early clinical development and teams in clinical practice.
